Improving Clinical Islet Transplantation Outcomes

Bart O Roep^{1

2}

Affiliations

¹ Department of Diabetes Immunology, Diabetes & Metabolism Research Institute at the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA broep@coh.org.
² Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands broep@coh.org.

Comment

Bart O Roep. Diabetes Care. 2020 Apr.

. 2020 Apr;43(4):698-700.

doi: 10.2337/dci19-0080.

Bart O Roep^{1

2}

¹ Department of Diabetes Immunology, Diabetes & Metabolism Research Institute at the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA broep@coh.org.
² Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands broep@coh.org.

No abstract available

Comment on

Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes.
Maffi P, Lundgren T, Tufveson G, Rafael E, Shaw JAM, Liew A, Saudek F, Witkowski P, Golab K, Bertuzzi F, Gustafsson B, Daffonchio L, Ruffini PA, Piemonti L; REP0211 Study Group. Maffi P, et al. Diabetes Care. 2020 Apr;43(4):710-718. doi: 10.2337/dc19-1480. Epub 2020 Feb 4. Diabetes Care. 2020. PMID: 32019854 Free PMC article. Clinical Trial.